Innospec Inc. (IOSP) Stock Forecast Oct. 16, 2026
Analysis updated on Oct. 16, 2026 (UTC) · Alpha · vs marketSwitch to Total · Nasdaq
Innospec Inc. (IOSP) stock forecast summary
Our AI ranks Innospec Inc. outside the neutral middle of its coverage (a directional signal). Create a free account and follow it to see the exact price target.
Innospec Inc. is a mid-cap company with a market capitalization of $2.38B. It ranks number 4 by market capitalization among the 17 Chemicals & Allied Products issuers in our coverage with a current forecast.
For IOSP, the Spearman rank correlation between our 90-day forecasts and the returns that followed is 21.0%, measured on 357 forecast dates between 2022-07-29 and 2026-07-17 on this stock's own recent history. A rank correlation runs from -100% to +100%: it measures whether higher forecasts were followed by higher returns, and a value near zero or below means the model has shown little skill on this stock. On the 30-day forecasts the same correlation is 12.0%, measured on 400 forecast dates between 2022-07-29 and 2026-09-16. Across our coverage, the out-of-sample test on 4495 stocks from 2025-01-06 to 2026-07-07 produced a positive net return in 82.5% of rebalance periods (factor-neutral book, net of estimated costs). Full backtest report
Expected return relative to the market over the horizon: a positive alpha means the model expects the stock to beat the market, whatever the market does. Ratings: strong buy ≥ +1.8%, buy ≥ +0.2%, sell < -0.9%, strong sell < -1.2% (top 15%, next 20%, middle 30%, next 20%, bottom 15% of the 2026-10-16 signals)
A free account shows the exact forecast, rating and rank of 3 tickers you follow, IOSP included.
Follow IOSP freeIOSP price chart and AI forecast
How IOSP ranks among 5184 stocks
90D Alpha forecasts of every company scored, cut into five relative ratings at the 15th, 35th, 65th and 85th percentiles (dashed lines).
Innospec Inc. (IOSP) fundamentals
Trailing twelve months. The industry median and the rank (1 = highest) are taken over the Chemicals & Allied Products peers listed below that report each metric.
Valuation & Market
| Metric | IOSP | Rank |
|---|---|---|
| Market Cap | $2.38B | 4/17 |
| P/E Ratio | 19.80x | – |
| P/B Ratio | 1.77x | 7/12 |
| EPS | $4.89 | – |
| Book Value/Share | $54.54 | – |
| Revenue/Share | $74.79 | – |
Profitability & Margins
| Metric | IOSP | Rank |
|---|---|---|
| ROE | 8.9% | 3/10 |
| ROA | 6.5% | 2/13 |
| ROIC | 8.7% | 3/12 |
| Gross Margin | 27.5% | 8/14 |
| Operating Margin | 7.0% | 4/13 |
| Net Margin | 6.5% | 2/12 |
| EBT Margin | 7.8% | 2/14 |
| Tax Rate | 14.7% | – |
Financial Health
| Metric | IOSP | Rank |
|---|---|---|
| Current Ratio | 2.78x | 6/16 |
| Quick Ratio | 1.87x | 4/13 |
| D/E Ratio | 0.37x | 7/13 |
| Financial Leverage | 1.37x | 7/14 |
| Interest Coverage | 36.8x | 1/14 |
| Working Capital | $657M | 3/16 |
Cash Flow
| Metric | IOSP | Rank |
|---|---|---|
| Operating Cash Flow | $126M | 8/15 |
| OCF Growth YoY | -8.3% | 6/8 |
Operational Efficiency
| Metric | IOSP | Rank |
|---|---|---|
| Asset Turnover | 1.00x | 1/13 |
| Receivables Turnover | 4.5x | 7/10 |
| Inventory Turnover | 4.0x | 9/13 |
| Fixed Assets Turnover | 6.3x | 2/13 |
| Days Sales Outstanding | 81 days | 4/10 |
| Days Inventory | 92 days | 5/13 |
| Payables Period | 46 days | 9/10 |
| Cash Conversion Cycle | 127 days | 3/7 |
Income Statement
| Metric | IOSP | Rank |
|---|---|---|
| Total Revenue | $1.84B | 5/13 |
| Operating Income | $129M | 3/14 |
| Net Income | $120M | 2/13 |
| R&D Expense | $52M | 4/10 |
| SG&A Expense | $304M | 5/13 |
| Cost of Goods Sold | $1.34B | 5/14 |
Dividend & Shareholder Information
| Metric | IOSP | Rank |
|---|---|---|
| Shares Outstanding | 25M | – |
| Net Income Growth | 595.4% | 1/6 |
| EPS Growth | 526.9% | 1/5 |
Balance Sheet Highlights (USD millions)
| Total Current Assets | $1.02B | 55.5% of assets |
| Cash & Short-term Investments | $250M | 13.6% of assets |
| Accounts Receivable | $409M | 22.1% of assets |
| Inventory | $337M | 18.3% of assets |
| Total Liabilities | $495M | 26.8% of assets |
| Short-term Debt | $199M | 10.8% of assets |
IOSP quarterly financials and insider trading
Innospec Inc. (IOSP) industry peers
Companies classified under the same SEC industry code as Innospec Inc. (Chemicals & Allied Products): 17 common-stock issuers with a forecast this week, one row per issuer, largest first. This is a classification match, not a curated list of competitors.
Reveal all forecasts · See exact % predictions for all competitors
Sign up free| Company | 90-Day AI Forecast (Alpha) | Market Cap |
|---|---|---|
| IOSP Innospec Inc. | ▼ | $2.38B |
| BCPC Balchem Corp | ▼ | $5.44B |
| PRM Perimeter Solutions, Inc. | ▶ | $4.34B |
| NGVT Ingevity Corp | ▶ | $2.40B |
| CC Chemours Co | ▶ | $1.92B |
| OLN Olin Corp | ▼ | $1.78B |
| HUN Huntsman Corp | ▼ | $1.49B |
| ECVT Ecovyst Inc. | ▶ | $1.13B |
| FMC Fmc Corp | ▲ | $709M |
| SLI Standard Lithium Ltd. | ▲ | $359M |
| ADUR Aduro Clean Technologies Inc. | ▼ | $330M |
| ACNT Ascent Industries Co. | ▼ | $122M |
| LQMT Liquidmetal Technologies Inc | ▶ | $71M |
| CITR Citrotech Inc. | ▶ | $62M |
| BLGO Biolargo, Inc. | ▲ | $23M |
| LOOP Loop Industries, Inc. | ▶ | $16M |
| GURE Gulf Resources, Inc. | ▲ | $6M |
Where IOSP sits on the market map
Innospec Inc. (IOSP) stock news
Loading...
Innospec Inc. (IOSP) stock forecast FAQ
What is the Innospec Inc. (IOSP) stock forecast?
Our AI ranks Innospec Inc. outside the neutral middle of its coverage (a directional signal). Create a free account and follow it to see the exact price target.
How accurate are Innospec Inc. stock predictions?
For IOSP, the Spearman rank correlation between our 90-day forecasts and the returns that followed is 21.0%, measured on 357 forecast dates between 2022-07-29 and 2026-07-17 on this stock's own recent history. A rank correlation runs from -100% to +100%: it measures whether higher forecasts were followed by higher returns, and a value near zero or below means the model has shown little skill on this stock. On the 30-day forecasts the same correlation is 12.0%, measured on 400 forecast dates between 2022-07-29 and 2026-09-16. Across our coverage, the out-of-sample test on 4495 stocks from 2025-01-06 to 2026-07-07 produced a positive net return in 82.5% of rebalance periods (factor-neutral book, net of estimated costs). Full backtest report
How often are Innospec Inc. forecasts updated?
Innospec Inc. forecasts are refreshed on trading days as the daily model run completes. The forecast on this page was produced on Oct. 16, 2026.
Which companies are Innospec Inc.'s industry peers?
17 issuers in our coverage, IOSP included, share the SEC industry code Chemicals & Allied Products. The largest are: Balchem Corp (BCPC), Perimeter Solutions, Inc. (PRM), Ingevity Corp (NGVT), Chemours Co (CC), Olin Corp (OLN), Huntsman Corp (HUN).
This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.